MiR-137 targets the EZH2 3′UTR in neuroblastoma cells, leading to decreased H3K27 methylation in the genomic regions of tumor suppressor genes clusterin (CLU) and nerve growth factor receptor (NGFR). The gene discussed is NGFR; the disease is neuroblastoma.